ARCHIVES

President’s Cancer Panel annual report finds barriers in translational research stall progress.

This article is from The Cancer Letter archive.

Vol. 31 No. 27 | July 8, 2005

Download PDF Visit The Full Archive

Related Articles

Letter: A Modest Proposal To Abolish FDA

January 26, 1996

Gleevec Improves Survival Of CML In Accelerated Phase

December 27, 2002

Dana-Farber Picks Rosenthal To Direct New Center For Integrated Therapies.

June 23, 2000

September issue of Business & Regulatory Report included–8 additional pages of industry news.

October 1, 2004

In Brief: Harris says She Won’t Ease up On Califano’s Antismoking Campaign – It Cost Him His Job

July 27, 1979

Breast Cancer Coalition Widens Its Agenda For Advocacy, Vows To Fight NIH Cutbacks

May 5, 1995